Dextroamphetamine is the dextrorotatory enantiomer of amphetamine[A2505]. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder[L6010,Label].
Synonyms
(S)-(+)-¦Â-phenylisopropylamine
(+)-¦Á-methylphenylethylamine
Dextroamphetamine
(S)-¦Á-methylbenzeneethanamine
Dextroamphetamine saccharate
(S)-(+)-amphetamine
Dexamphetamine
(S)-1-phenyl-2-propylamine
(¦ÁS)-¦Á-methylbenzeneethanamine
Dexamfetamine
d-amphetamine
(+)-(S)-amphetamine
Dexanfetamina
(+)-¦Á-methylphenethylamine
(S)-1-phenyl-2-aminopropane
(+)-amphetamine
Desamfetamina
Dextroamphetamine adipate
Dextroamphetamine sulfate
Dexamfetamina
(S)-amphetamine
Dexamfetaminum
Brand Names
Dextroamphetamine Sulfate
ProCentra
Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682